| __timestamp | Eli Lilly and Company | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 4733600000 | 8494000000 |
| Thursday, January 1, 2015 | 4796400000 | 9046000000 |
| Friday, January 1, 2016 | 5243900000 | 9095000000 |
| Sunday, January 1, 2017 | 5281800000 | 10554000000 |
| Monday, January 1, 2018 | 5051200000 | 10775000000 |
| Tuesday, January 1, 2019 | 5595000000 | 11355000000 |
| Wednesday, January 1, 2020 | 6085700000 | 12340000000 |
| Friday, January 1, 2021 | 7025900000 | 14277000000 |
| Saturday, January 1, 2022 | 7190800000 | 14135000000 |
| Sunday, January 1, 2023 | 9313400000 | 15048000000 |
| Monday, January 1, 2024 | 14271000000 | 17232000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical industry, innovation is the lifeblood that drives progress. Eli Lilly and Company and Johnson & Johnson, two titans in the field, have consistently invested heavily in research and development (R&D) to stay ahead. From 2014 to 2023, Johnson & Johnson has consistently outpaced Eli Lilly in R&D spending, with an average annual investment of approximately $11.5 billion, nearly double that of Eli Lilly's $6 billion. Notably, in 2023, Johnson & Johnson's R&D expenses peaked at $15 billion, marking a 77% increase from 2014. Meanwhile, Eli Lilly's investment grew by 97% over the same period, reaching $9.3 billion. This commitment to innovation underscores the companies' dedication to advancing healthcare solutions. As the industry faces new challenges, these investments are crucial in developing groundbreaking treatments and maintaining competitive advantage.
Research and Development Expenses Breakdown: Eli Lilly and Company vs GSK plc
Research and Development Investment: Eli Lilly and Company vs Sanofi
Research and Development: Comparing Key Metrics for Eli Lilly and Company and Grifols, S.A.
Comparing Innovation Spending: Eli Lilly and Company and MorphoSys AG
Comparing Innovation Spending: Eli Lilly and Company and Geron Corporation
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Taro Pharmaceutical Industries Ltd.
Research and Development: Comparing Key Metrics for Novo Nordisk A/S and Johnson & Johnson
R&D Insights: How Johnson & Johnson and Amgen Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Johnson & Johnson and Summit Therapeutics Inc.
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and BeiGene, Ltd.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Alpine Immune Sciences, Inc.
Comparing Innovation Spending: Johnson & Johnson and ImmunityBio, Inc.